Status:
UNKNOWN
SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Chronic Hemodialysis Patients
Caregivers of Chronic Hemodialysis Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: The preventive containment measures implemented in the COVID-19 pandemic are not feasible in chronic hemodialysis patients (HD) who need to attend their dialysis sessions 3 times a week. H...
Eligibility Criteria
Inclusion
- Subject of 18 years of age or older
- Chronic hemodialysis patients or caregiver of chronic hemodialysis patients
- signed consent
- Social Security affiliation.
Exclusion
- Pregnant or breastfeeding women
- Minors
- Adults under guardianship and trusteeship, persons deprived of their liberty,
- Participation in a SARS-COV2 vaccine study
Key Trial Info
Start Date :
June 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2020
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04420338
Start Date
June 5 2020
End Date
December 15 2020
Last Update
June 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, PACA, France, 13354